BioCorRx Inc. BICX

Company Overview

BioCorRx Inc. is a biotechnology and healthcare solutions company focused on the treatment of substance use disorders, with an emphasis on alcohol and opioid addiction. The company operates in the addiction recovery and behavioral health sectors and is publicly traded on the OTC market under the ticker BICX. Its primary business activities include the development and commercialization of addiction treatment programs and pharmaceutical therapies designed to support long-term recovery and relapse prevention.

The company’s core business lines include the BioCorRx Recovery Program and the development of sustained-release therapeutic candidates through its subsidiary BioCorRx Pharmaceuticals Inc. The recovery program combines behavioral counseling, peer support, and physician-supervised treatment protocols, historically incorporating naltrexone-based approaches for alcohol and opioid dependence. BioCorRx has evolved from an addiction treatment marketing and referral business into a development-stage biotechnology company pursuing FDA-regulated therapies for substance use disorders. Public disclosures indicate the company’s strategic positioning centers on addressing unmet needs in addiction treatment through integrated behavioral and pharmaceutical approaches.